Inflammation

Tanshinone IIA reduces inflammation in immune cells by affecting gene regulators and the TLR4-NF-κB signaling pathway

Updated

Abstract

Tanshinone IIA could reduce cytokine production, including tumor necrosis factor alpha (TNF-α), in LPS-induced RAW264.7 cells.

  • Tan IIA may inhibit the inflammatory response by decreasing levels of several inflammatory markers.
  • Significant reductions in messenger RNA (mRNA) expressions of IL-1β, TNF-α, and COX-2 were noted with Tan IIA treatment.
  • Tan IIA could diminish the activation of a specific signaling pathway (TLR4-MyD88-NF-κB) associated with inflammation.
  • Expression levels of various microRNAs were altered by Tan IIA, indicating potential regulatory effects on gene expression.
  • LPS treatment was associated with increased expression of certain microRNAs, which were decreased by Tan IIA.

Simplified

Full Text

Full text is available at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free